Malignant germ cell tumor of the mediastinum: A multimodality therapeutic approach

Hisao Asamura, Ryosuke Tsuchiya, Tomoyuki Goya, Haruhiko Kondo, Tsuguo Naruke, Nagahiro Saijo, Kehchi Suemasu

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Twenty-five patients with a malignant germ cell tumor of the mediastinum were treated at the National Cancer Center Hospital, Tokyo. Three patients had pure seminomas while 22 had a nonseminomatous histology. The treatment modalities consisted of surgery alone in 7 patients, surgery with chemotherapy and/or radiation in 14, and chemotherapy and/or radiation without surgery in 4. Cisplatin-based chemotherapy was administered in nine patients, one of whom successfully underwent high-dose chemotherapy with autologous bone marrow transplantation after resection of the tumor. A complete response was achieved in only five patients. The overall survival rate at 5 years was 33.5% and the median survival time was 51 weeks. Eight patients (32%), all of whom underwent surgery either with or without chemotherapy and/or radiation, were free of disease with a mean follow-up period of 439 weeks (72-1,120 weeks). The median survival times for 14 patients undergoing combined modality treatment, 7 patients undergoing surgery alone, and 4 patients undergoing chemotherapy and/or radiation were 83, 16, and 18 weeks, respectively.

Original languageEnglish
Pages (from-to)137-141
Number of pages5
JournalSurgery Today
Volume24
Issue number2
DOIs
Publication statusPublished - 1994 Feb
Externally publishedYes

Fingerprint

Germ Cell and Embryonal Neoplasms
Mediastinum
Drug Therapy
Radiation
Therapeutics
Cancer Care Facilities
Seminoma
Survival
Tokyo
Autologous Transplantation
Bone Marrow Transplantation
Cisplatin
Histology
Survival Rate

Keywords

  • germ cell tumor
  • mediastinal tumor

ASJC Scopus subject areas

  • Surgery

Cite this

Asamura, H., Tsuchiya, R., Goya, T., Kondo, H., Naruke, T., Saijo, N., & Suemasu, K. (1994). Malignant germ cell tumor of the mediastinum: A multimodality therapeutic approach. Surgery Today, 24(2), 137-141. https://doi.org/10.1007/BF02473395

Malignant germ cell tumor of the mediastinum : A multimodality therapeutic approach. / Asamura, Hisao; Tsuchiya, Ryosuke; Goya, Tomoyuki; Kondo, Haruhiko; Naruke, Tsuguo; Saijo, Nagahiro; Suemasu, Kehchi.

In: Surgery Today, Vol. 24, No. 2, 02.1994, p. 137-141.

Research output: Contribution to journalArticle

Asamura, H, Tsuchiya, R, Goya, T, Kondo, H, Naruke, T, Saijo, N & Suemasu, K 1994, 'Malignant germ cell tumor of the mediastinum: A multimodality therapeutic approach', Surgery Today, vol. 24, no. 2, pp. 137-141. https://doi.org/10.1007/BF02473395
Asamura, Hisao ; Tsuchiya, Ryosuke ; Goya, Tomoyuki ; Kondo, Haruhiko ; Naruke, Tsuguo ; Saijo, Nagahiro ; Suemasu, Kehchi. / Malignant germ cell tumor of the mediastinum : A multimodality therapeutic approach. In: Surgery Today. 1994 ; Vol. 24, No. 2. pp. 137-141.
@article{43ef0cdd59e244d0a1459348977880e2,
title = "Malignant germ cell tumor of the mediastinum: A multimodality therapeutic approach",
abstract = "Twenty-five patients with a malignant germ cell tumor of the mediastinum were treated at the National Cancer Center Hospital, Tokyo. Three patients had pure seminomas while 22 had a nonseminomatous histology. The treatment modalities consisted of surgery alone in 7 patients, surgery with chemotherapy and/or radiation in 14, and chemotherapy and/or radiation without surgery in 4. Cisplatin-based chemotherapy was administered in nine patients, one of whom successfully underwent high-dose chemotherapy with autologous bone marrow transplantation after resection of the tumor. A complete response was achieved in only five patients. The overall survival rate at 5 years was 33.5{\%} and the median survival time was 51 weeks. Eight patients (32{\%}), all of whom underwent surgery either with or without chemotherapy and/or radiation, were free of disease with a mean follow-up period of 439 weeks (72-1,120 weeks). The median survival times for 14 patients undergoing combined modality treatment, 7 patients undergoing surgery alone, and 4 patients undergoing chemotherapy and/or radiation were 83, 16, and 18 weeks, respectively.",
keywords = "germ cell tumor, mediastinal tumor",
author = "Hisao Asamura and Ryosuke Tsuchiya and Tomoyuki Goya and Haruhiko Kondo and Tsuguo Naruke and Nagahiro Saijo and Kehchi Suemasu",
year = "1994",
month = "2",
doi = "10.1007/BF02473395",
language = "English",
volume = "24",
pages = "137--141",
journal = "Surgery Today",
issn = "0941-1291",
publisher = "Springer Japan",
number = "2",

}

TY - JOUR

T1 - Malignant germ cell tumor of the mediastinum

T2 - A multimodality therapeutic approach

AU - Asamura, Hisao

AU - Tsuchiya, Ryosuke

AU - Goya, Tomoyuki

AU - Kondo, Haruhiko

AU - Naruke, Tsuguo

AU - Saijo, Nagahiro

AU - Suemasu, Kehchi

PY - 1994/2

Y1 - 1994/2

N2 - Twenty-five patients with a malignant germ cell tumor of the mediastinum were treated at the National Cancer Center Hospital, Tokyo. Three patients had pure seminomas while 22 had a nonseminomatous histology. The treatment modalities consisted of surgery alone in 7 patients, surgery with chemotherapy and/or radiation in 14, and chemotherapy and/or radiation without surgery in 4. Cisplatin-based chemotherapy was administered in nine patients, one of whom successfully underwent high-dose chemotherapy with autologous bone marrow transplantation after resection of the tumor. A complete response was achieved in only five patients. The overall survival rate at 5 years was 33.5% and the median survival time was 51 weeks. Eight patients (32%), all of whom underwent surgery either with or without chemotherapy and/or radiation, were free of disease with a mean follow-up period of 439 weeks (72-1,120 weeks). The median survival times for 14 patients undergoing combined modality treatment, 7 patients undergoing surgery alone, and 4 patients undergoing chemotherapy and/or radiation were 83, 16, and 18 weeks, respectively.

AB - Twenty-five patients with a malignant germ cell tumor of the mediastinum were treated at the National Cancer Center Hospital, Tokyo. Three patients had pure seminomas while 22 had a nonseminomatous histology. The treatment modalities consisted of surgery alone in 7 patients, surgery with chemotherapy and/or radiation in 14, and chemotherapy and/or radiation without surgery in 4. Cisplatin-based chemotherapy was administered in nine patients, one of whom successfully underwent high-dose chemotherapy with autologous bone marrow transplantation after resection of the tumor. A complete response was achieved in only five patients. The overall survival rate at 5 years was 33.5% and the median survival time was 51 weeks. Eight patients (32%), all of whom underwent surgery either with or without chemotherapy and/or radiation, were free of disease with a mean follow-up period of 439 weeks (72-1,120 weeks). The median survival times for 14 patients undergoing combined modality treatment, 7 patients undergoing surgery alone, and 4 patients undergoing chemotherapy and/or radiation were 83, 16, and 18 weeks, respectively.

KW - germ cell tumor

KW - mediastinal tumor

UR - http://www.scopus.com/inward/record.url?scp=0028203016&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028203016&partnerID=8YFLogxK

U2 - 10.1007/BF02473395

DO - 10.1007/BF02473395

M3 - Article

C2 - 8054792

AN - SCOPUS:0028203016

VL - 24

SP - 137

EP - 141

JO - Surgery Today

JF - Surgery Today

SN - 0941-1291

IS - 2

ER -